Test Price
2,800 AED✅ Home Collection Available
TUBA1A Gene Lissencephaly Type 3 Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily 8 AM – 11 PM).
- Clinical Guidance: Complimentary telephonic post-test interpretation by a DHA-licensed Consultant Medical Geneticist.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The TUBA1A Gene Lissencephaly Type 3 NGS Test identifies pathogenic variants in the TUBA1A gene associated with classic lissencephaly and cortical malformations using high-depth next-generation sequencing. This analysis detects mutations causing type 3 lissencephaly, enabling early diagnosis and genetic counselling.
| Aspect | Our Test (TUBA1A NGS) | Closest Alternative (Targeted Sanger) |
|---|---|---|
| Methodology | Full-gene Next-Generation Sequencing with CNV detection | Sanger sequencing of selected exons only |
| Variant Detection | SNVs, indels, and large deletions/duplications | Limited to point mutations and small indels |
| Turnaround Time | 3 to 4 Weeks | 4 to 6 Weeks |
Physician Insight & Safety Protocols
"Genetic testing for lissencephaly provides crucial information for diagnosis and family planning. Results must be interpreted in the context of clinical findings and always discussed with a pediatric neurologist. A negative result does not exclude a clinically suspected diagnosis." – Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA License: 9294403
Medication Safety Advisory
⚠️ Medication Warning
Do not discontinue any prescribed antiepileptic or other medication without direct consultation with your treating physician.
Exclusion Criteria & Emergency Red Flags
- Active febrile illness or uncontrolled seizure at time of blood collection.
- Known severe coagulopathy or platelet disorder.
- Inability to obtain informed consent from legal guardian for a minor.
- Seek emergency care if the child develops new-onset apnea, prolonged seizures, or feeding difficulties.
Patient FAQ & Clinical Guidance
1. What exactly does the TUBA1A gene lissencephaly test detect?
A: This test identifies disease-causing DNA variants in the entire TUBA1A gene that lead to type 3 lissencephaly, providing a definitive molecular diagnosis that guides prognosis and recurrence risk counselling.
2. How should I prepare my child for the blood draw?
A: Ensure your child is well-hydrated and calm; no fasting is required, but you may apply a topical anaesthetic cream 30 minutes before the home collection visit to minimise discomfort. Our paediatric phlebotomist uses specialised paediatric butterfly needles for minimal pain.
3. How long does it take to receive the result?
A: The standard reporting time is 3 to 4 weeks from sample receipt, because comprehensive NGS analysis and clinical interpretation require multiple quality-control steps to ensure accuracy of every nucleotide.
4. Is genetic counselling mandatory before this test?
A: Yes, prior genetic counselling is required to construct a family pedigree, discuss implications, and obtain informed consent. Our clinical team coordinates this session before sample collection.
UAE Regulatory & Data Privacy Adherence
Data Privacy & Health Information Protection: This service complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is encrypted and processed under strict confidentiality protocols. Clinical safety and patient consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability.
Accreditation: ISO 9001:2015 Quality Management System – Certificate INT/EGQ/2509DA/3139.
Clinical & Logistical Metadata
| Test Name | TUBA1A Gene Lissencephaly Type 3 Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA), Extracted DNA, or FTA Card – Collected via VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily 8 AM – 11 PM) |
| Methodology Used | Next-Generation Sequencing (NGS) with full TUBA1A gene coverage, CNV detection, and variant classification per ACMG guidelines |
| ICD-10-CM Code | Q04.3, Q02, Z13.71 |
| LOINC Code | 101673-8 |
| DHA Facility License & Address | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians